120 related articles for article (PubMed ID: 38926488)
1. Towards a better understanding of idiopathic epilepsy through metabolic fingerprinting of cerebrospinal fluid in dogs.
Verdoodt F; Bhatti SFM; Kragic K; Van Ham L; Vanhaecke L; Hesta M; Hemeryck LY
Sci Rep; 2024 Jun; 14(1):14750. PubMed ID: 38926488
[TBL] [Abstract][Full Text] [Related]
2. Gas chromatography-mass spectrometry-based metabolic profiling of cerebrospinal fluid from epileptic dogs.
Hasegawa T; Sumita M; Horitani Y; Tamai R; Tanaka K; Komori M; Takenaka S
J Vet Med Sci; 2014 Apr; 76(4):517-22. PubMed ID: 24334864
[TBL] [Abstract][Full Text] [Related]
3. Comparison of concentrations of γ-aminobutyric acid and glutamate in cerebrospinal fluid of dogs with idiopathic epilepsy with and without seizure-related magnetic resonance imaging hyperintense areas in the limbic system.
Creevy KE; Gagnepain JF; Platt SR; Edwards GL; Kent M
Am J Vet Res; 2013 Aug; 74(8):1118-25. PubMed ID: 23879850
[TBL] [Abstract][Full Text] [Related]
4. Cerebrospinal fluid gamma-aminobutyric acid and glutamate values in dogs with epilepsy.
Podell M; Hadjiconstantinou M
Am J Vet Res; 1997 May; 58(5):451-6. PubMed ID: 9140549
[TBL] [Abstract][Full Text] [Related]
5. Confirmation of neurometabolic diagnoses using age-dependent cerebrospinal fluid metabolomic profiles.
Peters TMA; Engelke UFH; de Boer S; van der Heeft E; Pritsch C; Kulkarni P; Wevers RA; Willemsen MAAP; Verbeek MM; Coene KLM
J Inherit Metab Dis; 2020 Sep; 43(5):1112-1120. PubMed ID: 32406085
[TBL] [Abstract][Full Text] [Related]
6. Metabolome of canine and human saliva: a non-targeted metabolomics study.
Turunen S; Puurunen J; Auriola S; Kullaa AM; Kärkkäinen O; Lohi H; Hanhineva K
Metabolomics; 2020 Aug; 16(9):90. PubMed ID: 32840693
[TBL] [Abstract][Full Text] [Related]
7. The chaperone protein clusterin may serve as a cerebrospinal fluid biomarker for chronic spinal cord disorders in the dog.
Shafie IN; McLaughlin M; Burchmore R; Lim MA; Montague P; Johnston PE; Penderis J; Anderson TJ
Cell Stress Chaperones; 2014 May; 19(3):311-20. PubMed ID: 23990410
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory and excitatory neurotransmitters in the cerebrospinal fluid of epileptic dogs.
Ellenberger C; Mevissen M; Doherr M; Scholtysik G; Jaggy A
Am J Vet Res; 2004 Aug; 65(8):1108-13. PubMed ID: 15334845
[TBL] [Abstract][Full Text] [Related]
9. Multi Platforms Strategies and Metabolomics Approaches for the Investigation of Comprehensive Metabolite Profile in Dogs with
Rubić I; Burchmore R; Weidt S; Regnault C; Kuleš J; Barić Rafaj R; Mašek T; Horvatić A; Crnogaj M; Eckersall PD; Novak P; Mrljak V
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163517
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics in cerebrospinal fluid of patients with amyotrophic lateral sclerosis: an untargeted approach via high-resolution mass spectrometry.
Blasco H; Corcia P; Pradat PF; Bocca C; Gordon PH; Veyrat-Durebex C; Mavel S; Nadal-Desbarats L; Moreau C; Devos D; Andres CR; Emond P
J Proteome Res; 2013 Aug; 12(8):3746-54. PubMed ID: 23859630
[TBL] [Abstract][Full Text] [Related]
11. Elucidation of the complex metabolic profile of cerebrospinal fluid using an untargeted biochemical profiling assay.
Kennedy AD; Pappan KL; Donti TR; Evans AM; Wulff JE; Miller LAD; Reid Sutton V; Sun Q; Miller MJ; Elsea SH
Mol Genet Metab; 2017 Jun; 121(2):83-90. PubMed ID: 28412083
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic utility of cerebrospinal fluid analysis in dogs with suspected idiopathic epilepsy.
Gilbert SE; Cardy TJ; Bertram S; Taylor-Brown F
Aust Vet J; 2021 Jan; 99(1-2):1-5. PubMed ID: 32893907
[TBL] [Abstract][Full Text] [Related]
13. A validated multi-matrix platform for metabolomic fingerprinting of human urine, feces and plasma using ultra-high performance liquid-chromatography coupled to hybrid orbitrap high-resolution mass spectrometry.
De Paepe E; Van Meulebroek L; Rombouts C; Huysman S; Verplanken K; Lapauw B; Wauters J; Hemeryck LY; Vanhaecke L
Anal Chim Acta; 2018 Nov; 1033():108-118. PubMed ID: 30172316
[TBL] [Abstract][Full Text] [Related]
14. Identification of cerebrospinal fluid metabolites as biomarkers for neurobrucellosis by liquid chromatography-mass spectrometry approach.
Yang H; Wang Z; Shi S; Yu Q; Liu M; Zhang Z
Bioengineered; 2022 Mar; 13(3):6996-7010. PubMed ID: 35249459
[TBL] [Abstract][Full Text] [Related]
15. Cerebrospinal fluid and blood lactate concentrations as prognostic biomarkers in dogs with meningoencephalitis of unknown origin.
Portero M; Martínez de Merlo E; Pérez C; Benito M; Daza MA; Fragio C
Vet J; 2019 Dec; 254():105395. PubMed ID: 31836169
[TBL] [Abstract][Full Text] [Related]
16. Metabolic profiling of serum from dogs with pituitary-dependent hyperadrenocorticism.
Muñoz-Prieto A; Rubić I; Horvatic A; Rafaj RB; Cerón JJ; Tvarijonaviciute A; Mrljak V
Res Vet Sci; 2021 Sep; 138():161-166. PubMed ID: 34147706
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of decreased glucose levels in the cerebrospinal fluid of dogs].
Weber J; Maiolini A; Tipold A
Tierarztl Prax Ausg K Kleintiere Heimtiere; 2012 Oct; 40(5):325-32. PubMed ID: 23076016
[TBL] [Abstract][Full Text] [Related]
18. Cerebrospinal fluid metabolomics reveals altered waste clearance and accelerated aging in HIV patients with neurocognitive impairment.
Cassol E; Misra V; Dutta A; Morgello S; Gabuzda D
AIDS; 2014 Jul; 28(11):1579-91. PubMed ID: 24752083
[TBL] [Abstract][Full Text] [Related]
19. Untargeted detection of the carbonyl metabolome by chemical derivatization and liquid chromatography-tandem mass spectrometry in precursor ion scan mode: Elucidation of COVID-19 severity biomarkers.
Gomez-Gomez A; Rodríguez-Morató J; Haro N; Marín-Corral J; Masclans JR; Pozo OJ
Anal Chim Acta; 2022 Mar; 1196():339405. PubMed ID: 35151400
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
